97 filings
Page 5 of 5
8-K
4avmtv6
10 Jun 22
Entry into a Material Definitive Agreement
4:01pm
8-K
x9tmqanvletgqjv
27 May 22
Allarity Therapeutics Reports First Quarter 2022 Financial Results
5:29pm
8-K
z7szng7q bjz85lkl
27 May 22
Regulation FD Disclosure
6:01am
8-K/A
qta1fvfon5
19 May 22
Correction Notice to Press Release Announcing Financial Results For the Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
6:05am
8-K
hceruacp6kk
16 May 22
Allarity Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
7:54pm
8-K
rrl 9fhh4tsjqsigq1uu
6 May 22
Entry into a Material Definitive Agreement
5:09pm
8-K
ii0nwuyoujenm6w6d4mz
22 Apr 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:28pm
8-K
v7gmxhcktzcsyv7fh7
18 Apr 22
Entry into a Material Definitive Agreement
5:06pm
8-K
8y94lcud414p
1 Apr 22
Entry into a Material Definitive Agreement
4:50pm
8-K/A
qr9v97v8
1 Apr 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:30pm
8-K
urtcc20zltv ffjk
31 Mar 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:16pm
8-K
xd4p0ifu43ewcv
18 Jan 22
Regulation FD Disclosure
12:00am
8-K
75vuzh0rho4s
6 Jan 22
Entry into a Material Definitive Agreement
4:30pm
8-K
a795wf3iacj349cwg
22 Dec 21
Changes in Registrant's Certifying Accountant
5:05pm
8-K
r08l7ussm4assaq
22 Dec 21
Allarity Therapeutics Closes Its Recapitalization, Share Exchange, and $20M PIPE Investment; Lists on U.S. Nasdaq Stock Market
5:00pm
8-K
tr8m86kih6a9rq
20 Dec 21
Material Modifications to Rights of Security Holders
4:30pm
8-K
y9ka37
10 Dec 21
Entry into a Material Definitive Agreement
4:34pm